Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Coordinated nasal mucosa-mediated immunity accelerates recovery from COVID-19.
Cass SP, Nicolau DV Jr, Baker JR, Mwasuku C, Ramakrishnan S, Mahdi M, Barnes PJ, Donnelly LE, Martinez-Nunez RT, Russell REK, Bafadhel M. Cass SP, et al. Among authors: nicolau dv jr. ERJ Open Res. 2024 May 13;10(3):00919-2023. doi: 10.1183/23120541.00919-2023. eCollection 2024 May. ERJ Open Res. 2024. PMID: 38746861 Free PMC article.
Epigenome erosion and SOX10 drive neural crest phenotypic mimicry in triple-negative breast cancer.
Saunus JM, De Luca XM, Northwood K, Raghavendra A, Hasson A, McCart Reed AE, Lim M, Lal S, Vargas AC, Kutasovic JR, Dalley AJ, Miranda M, Kalaw E, Kalita-de Croft P, Gresshoff I, Al-Ejeh F, Gee JMW, Ormandy C, Khanna KK, Beesley J, Chenevix-Trench G, Green AR, Rakha EA, Ellis IO, Nicolau DV Jr, Simpson PT, Lakhani SR. Saunus JM, et al. Among authors: nicolau dv jr. NPJ Breast Cancer. 2022 May 2;8(1):57. doi: 10.1038/s41523-022-00425-x. NPJ Breast Cancer. 2022. PMID: 35501337 Free PMC article.
Early Th2 inflammation in the upper respiratory mucosa as a predictor of severe COVID-19 and modulation by early treatment with inhaled corticosteroids: a mechanistic analysis.
Baker JR, Mahdi M, Nicolau DV Jr, Ramakrishnan S, Barnes PJ, Simpson JL, Cass SP, Russell REK, Donnelly LE, Bafadhel M. Baker JR, et al. Among authors: nicolau dv jr. Lancet Respir Med. 2022 Jun;10(6):545-556. doi: 10.1016/S2213-2600(22)00002-9. Epub 2022 Apr 7. Lancet Respir Med. 2022. PMID: 35397798 Free PMC article. Clinical Trial.
Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial.
Yu LM, Bafadhel M, Dorward J, Hayward G, Saville BR, Gbinigie O, Van Hecke O, Ogburn E, Evans PH, Thomas NPB, Patel MG, Richards D, Berry N, Detry MA, Saunders C, Fitzgerald M, Harris V, Shanyinde M, de Lusignan S, Andersson MI, Barnes PJ, Russell REK, Nicolau DV Jr, Ramakrishnan S, Hobbs FDR, Butler CC; PRINCIPLE Trial Collaborative Group. Yu LM, et al. Among authors: nicolau dv jr. Lancet. 2021 Sep 4;398(10303):843-855. doi: 10.1016/S0140-6736(21)01744-X. Epub 2021 Aug 10. Lancet. 2021. PMID: 34388395 Free PMC article. Clinical Trial.
Patterns of bacterial motility in microfluidics-confining environments.
Tokárová V, Sudalaiyadum Perumal A, Nayak M, Shum H, Kašpar O, Rajendran K, Mohammadi M, Tremblay C, Gaffney EA, Martel S, Nicolau DV Jr, Nicolau DV. Tokárová V, et al. Among authors: nicolau dv jr. Proc Natl Acad Sci U S A. 2021 Apr 27;118(17):e2013925118. doi: 10.1073/pnas.2013925118. Proc Natl Acad Sci U S A. 2021. PMID: 33875583 Free PMC article.
Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial.
Ramakrishnan S, Nicolau DV Jr, Langford B, Mahdi M, Jeffers H, Mwasuku C, Krassowska K, Fox R, Binnian I, Glover V, Bright S, Butler C, Cane JL, Halner A, Matthews PC, Donnelly LE, Simpson JL, Baker JR, Fadai NT, Peterson S, Bengtsson T, Barnes PJ, Russell REK, Bafadhel M. Ramakrishnan S, et al. Among authors: nicolau dv jr. Lancet Respir Med. 2021 Jul;9(7):763-772. doi: 10.1016/S2213-2600(21)00160-0. Epub 2021 Apr 9. Lancet Respir Med. 2021. PMID: 33844996 Free PMC article. Clinical Trial.
29 results